Correlation of p53 status with the response to chemotherapy-based treatment in esophageal cancer: a meta-analysis (Q27852124)

5

object named as

Kong-Jia Luo

0 references

Jian-Hua Fu

10

object named as

Jian-Hua Fu

0 references

author name string

Shui-Shen Zhang

1

0 references

Qing-Yuan Huang

2

0 references

Xuan Xie

4

0 references

Jing Wen

6

0 references

Xiao-Li Cai

7

0 references

Fu Yang

8

0 references

Yi Hu

Annals of Surgical Oncology

9

0 references

publication date

July 2013

0 references

published in

0 references

volume

20

0 references

issue

7

0 references

page(s)

2419-27

0 references

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Biomarkers of response to therapy in oesophago-gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Blinded by the Light: The Growing Complexity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Predicting response to cancer chemotherapy: the role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Clinical outcomes of enteroscopy using the double-balloon method for strictures of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Prognostic significance of TP53 tumor suppressor gene expression and mutations in human osteosarcoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Prognostic value of p53 mutations in patients with locally advanced esophageal carcinoma treated with definitive chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Apoptotic and proliferative indexes in esophageal cancer: Predictors of response to neoadjuvant therapy apoptosis and proliferation in esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Mdm2 promotes the rapid degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2859-4